Experimental GLP-1 Pill Aleniglipron Shows 12% Weight Loss in Trial
An experimental daily oral GLP-1 pill, aleniglipron, demonstrated up to 12.1% weight loss over 36 weeks in a clinical trial, offering an easier-to-produce alternative to injectables.